Síndrome de apnea obstructiva del sueño y sus consecuencias cardiovasculares / sleep apnea and its cardiovascular consequences

El sueño es fundamental para una serie de funciones corporales, incluyendo el metabolismo de radicales libres, secreción hormonal y fijación de la memoria. Existen evidencias crecientes de que la simple restricción en el número de horas de sueño puede ser perjudicial para el sistema cardiovascular. Por ejemplo, estudios de cohorte sugieren que dormir menos de 5 horas/noche puede aumentar el riesgo de desarrollar hipertensión arterial sistémica (HAS), infarto agudo del miocardio (IAM) y accidente vascular cerebral (AVC). Otro creciente foco de interés en la medicina actual son los trastornos respiratorios del sueño. En este artículo, nos enfocaremos a los trastornos respiratorios del sueño de mayor interés para el cardiólogo, el síndrome apnea obstructiva del sueño (SAOS) y la apnea central asociada a la respiración de Cheyne-Stokes. Además de extremadamente comunes, existen evidencias de que estos trastornos respiratorios del sueño, una vez presentes, pueden contribuir al desarrollo o empeoramiento de las enfermedades cardiovasculares

Sleep is essential for several physiological functions, including free radical metabolism, hormone secretion, and memory. There is growing evidence that restricting the number of hours of sleep can be harmful to the cardiovascular system. For example, cohort studies suggest that sleeping less than 5 hours/night may increase the risk of developing systemic arterial hypertension, acute myocardial infarction and strokes. Another growing focus of interest in current medicine is sleep respiratory disturbances. In this article, we will focus on the respiratory sleep disorders of greatest interest to the cardiologist, obstructive sleep apnea syndrome and central Cheyne-Stokes respiration-associated apnea. In addition, there is evidence that breathing sleep disorders are extremely common and once present can contribute to the development or worsening of cardiovascular disease

Associations of Sedentary Time and Physical Activity with Metabolic Syndrome among Chinese Adults: Results from the China Health and Nutrition Survey / 生物医学与环境科学（英文）

Objective@#This study aimed to determine the independent and joint associations of sedentary time (ST) and physical activity (PA) with metabolic syndrome (MetS) and its components among Chinese adults.@*Methods@#The study analyzed data from 4,865 adults aged ≥ 18 years who participated in the 2009 and 2015 China Health and Nutrition Surveys (CHNS). Four types of leisure ST and three types of PA self-reported at baseline were collected. Multivariable logistic regressions were used to determine the independent and joint associations of ST and PA with the odds of MetS or its components.@*Results@#For independent effects, higher levels of television time and total leisure ST was associated with higher MetS risk [odds ratio ( @*Conclusions@#MVPA and total PA have independent preventive effects, and sedentary behavior (mainly watching TV) has an unsafe effect on MetS and its components. Strengthening the participation of MVPA and combining the LPA to replace the TV-based ST to increase the total PA may be necessary to reduce the prevalence of MetS in Chinese adults.

Utilidad del fenotipo hipertensión-obesidad abdominal para identificar personas con riesgo cardiovascular global moderado y alto / Use of the hypertension- abdominal obesity phenotype to identify people with moderate and high overall cardiovascular risk

Introducción: La obesidad está relacionada con un riesgo elevado de enfermedades no transmisibles. Una tendencia creciente en la prevalencia de la obesidad desde principios de la década de 1980 ha planteado una importante carga de salud de la población en todo el mundo. Objetivos: Determinar la utilidad del fenotipo hipertensión-obesidad abdominal para identificar personas con riesgo cardiovascular global moderado o alto en adultos con exceso de peso corporal y si esta es superior a la de otros binomios fenotípicos descritos y al síndrome metabólico. Métodos: Estudio observacional, descriptivo y transversal que incluyó 257 personas de 35 a 70 años. Variables estudiadas: edad, sexo, peso, talla, índice de masa corporal, circunferencia de la cintura, presión arterial, colesterol, triglicéridos, colesterol-HDL y glucemia en ayunas. Se determinó la presencia del síndrome metabólico según los criterios de la declaración provisional conjunta [Joint Interim Statement (JIS), siglas en inglés], además se estudiaron los fenotipos hipertensión-obesidad abdominal, hipertrigliceridemia-obesidad abdominal e hiperglucemia-obesidad abdominal. El riesgo cardiovascular global fue evaluado mediante las tablas de Gaziano. Resultados: El 81,7 por ciento (210/257) de los sujetos presentó el fenotipo hipertensión-obesidad abdominal y la frecuencia de riesgo cardiovascular moderado-alto fue de 28,0 por ciento (72/257). El fenotipo hipertensión-obesidad abdominal detectó la mayor proporción de sujetos con riesgo cardiovascular moderado-alto (64 de los 72); el riesgo cardiovascular moderado-alto estaba presente en la mayoría con este fenotipo (88,8 por ciento), diferente de aquellos sin el fenotipo (11,1 por ciento). La sensibilidad (88,9 por ciento) y el valor predictivo negativo (83,0 por ciento) muestran que el fenotipo hipertensión-obesidad abdominal es un binomio útil para detectar individuos con riesgo cardiovascular moderado-alto. Conclusiones: La utilidad del fenotipo hipertensión-obesidad abdominal es superior a la de otros binomios fenotípicos y al síndrome metabólico para identificar personas con riesgo cardiovascular moderado-alto. La elevada sensibilidad y el alto valor predictivo negativo del fenotipo hipertensión-obesidad abdominal, así como la simplicidad de su determinación, lo convierten en una buena opción para pesquisar sujetos con este riesgo(AU)

Introduction: Obesity is linked to a high risk of non-communicable diseases. A growing trend in the prevalence of obesity since the early 1980s has posed a significant population´s health burden worldwide. Objectives: Determine the usefulness of the hypertension- abdominal obesity´s phenotype to identify cases with moderate or high overall cardiovascular risk in adults with excess body weight and whether it is superior to that of other phenotypic binomials described and to the metabolic syndrome. Methods: Observational, descriptive and cross-sectional study that included 257 people from 35 to 70 years old. Variables studied: age, sex, weight, size, body mass index, waist circumference, blood pressure, cholesterol, triglycerides, HDL cholesterol and fasting blood glucose. The presence of metabolic syndrome was determined according to the criteria of the Joint Interim Statement (JIS), and hypertension- abdominal obesity phenotypes, abdominal hypertriglyceridemia-obesity and hyperglycemia- abdominal obesity were also studied. The overall cardiovascular risk was assessed using Gaziano's tables. Results: 81.7 percent (210/257) of subjects had the hypertension-abdominal obesity´s phenotype and the frequency of moderate-high cardiovascular risk was 28.0 percent (72/257).The hypertension- abdominal obesity´s phenotype detected the highest proportion of subjects at moderate-high cardiovascular risk (64 of the 72); moderate-high cardiovascular risk was present in most of the subjects with this phenotype (88.8 percent), different from those without the phenotype (11.1 percent).Sensitivity (88.9 percent) and the negative predictive value (83.0 percent) show that the hypertension- abdominal obesity´s phenotype is a useful binomial for detecting individuals with moderate-high cardiovascular risk. Conclusions: The usefulness of the hypertension- abdominal obesity phenotype is superior to that of other phenotypic binomials and to the metabolic syndrome in order to identify people with moderate-high cardiovascular risk. The high sensitivity and high negative predictive value of the hypertension- abdominal obesity phenotype, as well as the simplicity of its determination, make it a good option for researching subjects with this risk(AU)

Etapas del climaterio y enfermedad cardiovascular en mujeres diabéticas de edad mediana / Stages of Climacteric and Cardiovascular Disease among Middle-Aged Diabetic Women

RESUMEN Introducción: La diabetes mellitus tipo 2 es considerada una situación de alto riesgo cardiovascular. En la mujer con diabetes se añade el riesgo que representa el déficit estrogénico posmenopáusico. Objetivo: Determinar la frecuencia de enfermedad cardiovascular en las etapas del climaterio. Métodos: Se realizó un estudio transversal y descriptivo con 611 mujeres con diabetes mellitus tipo 2 en edad mediana (40-59 años), que ingresaron consecutivamente en el Centro de Atención al Diabético de Bayamo, Granma, desde el año 2010 al 2017. Se excluyeron los casos con menopausia artificial. Se empleó la prueba de chi cuadrado para comprobar la relación que pudiera existir entre las variables cualitativas, mientras que para comparar los valores promedio de las variables cuantitativas entre los grupos se utilizó t de Student. Resultados: La frecuencia de hipertensión arterial, hipercolesterolemia y síndrome metabólico fue claramente superior en las mujeres posmenopáusicas que en las premenopáusicas (p = 0,0257; p = 0,0391 y p = 0,0591, respectivamente). Las enfermedades cardiovasculares aumentaron significativamente con la menopausia y con el tiempo de ocurrencia de este evento (p = 0,0014). La relación fue más notoria en el caso de la cardiopatía isquémica y la enfermedad arterial periférica (p = 0,0521 y p = 0,0011, respectivamente). Conclusiones: En las mujeres con diabetes mellitus tipo 2 la enfermedad cardiovascular aumenta significativamente con el avance de la peri a la posmenopausia tardía, fundamentalmente la cardiopatía isquémica y la enfermedad arterial periférica(AU)

ABSTRACT Introduction: Type 2 diabetes mellitus is considered a situation of high cardiovascular risk. Among diabetic women, the risk for postmenopausal estrogen deficiency is added. Objective: To determine the frequency of cardiovascular disease in climacteric stages. Methods: A cross-sectional and descriptive study was carried out with 611 middle-aged (40-59 years old) women with type 2 diabetes mellitus and who were admitted consecutively to the Diabetic Care Center in Bayamo city, Granma, from 2010 to 2017. The cases with artificial menopause were not included in the study. The chi-square test was used to verify the relationship that might exist between qualitative variables, while Student's t test was used to compare the average values of the quantitative variables between the groups. Results: The frequency of arterial hypertension, hypercholesterolemia and metabolic syndrome was clearly higher among postmenopausal women than among premenopausal women (p = 0.0257, p = 0.0391, and p = 0.0591, respectively). Cardiovascular disease increased significantly with menopause and with the time of occurrence of this event (p = 0.0014). The relationship was more noticeable in the case of ischemic heart disease and peripheral arterial disease (p = 0.0521 and p = 0.0011, respectively). Conclusions: In women with type 2 diabetes mellitus, cardiovascular disease increases significantly with the progression from the perimenopausal stage to the late postmenopausal stage, mainly ischemic heart disease and peripheral arterial disease(AU)

Estado nutricional, síndrome metabólico e inflamación en pacientes con enfermedad de Chagas / Nutritional condition, metabolic syndrome and inflammation in patients with Chagas disease

El propósito de este estudio fue describir la asociación entre el estado nutricional, la presencia de síndrome metabólico (SM), y el estado inflamatorio, en pacientes con Enfermedad de Chagas (ECh), atendidos en la consulta externa del Instituto de Medicina Tropical en Caracas. El estudio fue de tipo transversal y correlacional, en el cual se seleccionaron 34 pacientes a los cuales se les realizó un diagnóstico parasitológico, inmunológico y molecular de la ECh. Se evaluaron variables antropométricas, clínicas y bioquímicas, así como el SM el cual fue determinado por los criterios del III Panel estadounidense para el Tratamiento de Adultos del Programa Nacional de Educación sobre el Colesterol (ATP-III, por sus siglas en inglés). Se encontró que la mayoría de los pacientes presentaron sobrepeso u obesidad (73,5%), un porcentaje de grasa corporal (% GC) alto o muy alto (82,3%), y obesidad abdominal (61,8 %). La frecuencia de SM fue de 29,4% y más del 90% mostraron valores elevados de Proteína C Reactiva ultrasensible (PCRus). Valores más elevados del IMC se asociaron con un estadio más avanzado de la ECh. Los sujetos con presencia de ADN de Tripanosoma cruzi (T. cruzi) circulante en sangre, presentaron mayor % GC, y en su mayoría, fueron diagnosticados con SM. En conclusión, los pacientes evaluados mostraron un exceso de adiposidad, que puede favorecer el estado inflamatorio, el desarrollo de SM y la progresión de la ECh(AU)

The purpose of the study was to describe the association between nutritional and inflammatory status and the presence of metabolic syndrome (MS) on patients with Chagas disease (CD) treated at the Outpatient Services of the Tropical Medicine Institute in Caracas, Venezuela. The study was cross-sectional and correlational. Thirty-four (34) patients were selected and a molecular, immunological, and parasitological diagnostic test was ran for Chagas disease. Anthropometric, clinic, and biochemical variables were evaluated, and the MS was determined using National Cholesterol Education Program Expert/Adult Treatment Panel III (ATP-III) criteria. The results showed a high percentage of patients overweight or presenting obesity (73.5%), a high and very high percentage of body fat (82.3%), and abdominal obesity (61.8%). The prevalence of MS was 29,4% and more than 90% of patients showed elevated values of high sensitivity C-reactive protein (hsCRP). Higher body-mass index values were associated with advanced stages of the CD. Subjects in the presence of T. cruzi DNA in the blood showed a greater percentage of body fat and, most of them, were diagnosed with MS. In conclusion, the evaluated patients showed an excess of adiposity which may favor an inflammatory status, the development of the MS, and the progress of the CD(AU)

Síndrome metabólico, hígado graso no alcohólico y hepatocarcinoma / Metabolic syndrome, nonalcoholic fatty liver disease and hepatocellular carcinoma

En las últimas décadas, los cambios en el estilo de vida pro-vocaron un incremento en la prevalencia del síndrome meta-bólico y que la enfermedad por hígado graso no alcohólico (nonalcoholic fatty liver disease, NAFLD sus siglas en inglés) se convierta en la enfermedad hepática crónica más fre-cuente en todo el mundo. Los componentes del síndrome metabólico no son sólo altamente prevalentes en pacientes con hígado graso no alcohólico, sino que a la vez aumentan el riesgo de desarrollarlo. Esta relación bidireccional ha sido claramente establecida. Asimismo se considera que NAFLD podría ser el componente hepático del síndrome metabólico. Aunque NAFLD se considera principalmente una enfermedad benigna, puede progresar a fibrosis hepática grave y carcino-ma hepatocelular (CHC), incluso se encontraría este último en hígados no cirróticos. El objetivo de esta revisión es determinar los procesos fisio-patológicos comunes a estas entidades, cuáles son las estra-tegias diagnósticas recomendadas y cuáles las intervenciones terapéuticas actualmente aprobadas.

Insulin dysregulation in horses with induced obesity / Desregulação da insulina em equinos com obesidade induzida

Insulin deregulation (ID) is a central player in the pathophysiology of equine metabolic syndrome (EMS), which is associated with generalized and/or regional obesity. The objective of this experiment was to characterize the alterations in the hormonal profile in horses exposed to a hypercaloric diet. A total of nine Mangalarga Marchador adult horses with initial body condition score (BCS) of 2.9±1/9 (mean±SD) were submitted to a high calorie grain-rich diet for 5 months. The data was collected before the start of the experiment and every 15 days until the end of the experiment and glucose and insulin concentrations were measured in the plasma. Proxies G:I, RISQI, HOMA-IR and MIRG were calculated. The low-dose oral glucose tolerance test (OGTT) was performed and the total area under the glucose (GTA) and insulin (ITA) curves at three different timepoints (before inducing obesity, after 90 days and after 150 days) was used. Analysis of variance of the results was performed considering the time effects and the means were compared with repeated measures by the Tukey's test (P≤0.05). The ID was observed during the first 90 days of the experiment and was characterized as a decompensated ID, showing an increase of basal glucose and insulin plasma levels, changes in all proxies and a significant increase in GTA (P<0.001) and ITA (P<0.05). However, a clear compensation of the ID was evident after 150 days of experiment, which was supported by data from the insulin secretory response of ß cells of the pancreas that showed an increase in insulin plasma levels, after fasting or exposure to gastric glucose, with a concomitant decrease in fasting glucose and fructosamine levels, and a decrease of GTA and marked increase of ITA (P<0.0001) in the dynamic test. These findings confirm the occurrence of hyperinsulinemia associated with insulin deregulation in Mangalarga Marchador horses exposed to hypercaloric diets.(AU)

A desregulação insulínica (DI) é o ponto central dos mecanismos fisiopatológicos da síndrome metabólica equina (SME), que é associada à obesidade generalizada e/ou regional. O objetivo deste experimento foi caracterizar as alterações no perfil hormonal em equinos submetidos à dieta hipercalórica. Foram utilizados nove equinos Mangalarga Marchador adultos com escore corporal (EC) médio (±DP) inicial de 2,9±1 (escala de 1-9) submetidos à dieta hipercalórica atingindo um EC de 8,3±1 após cinco meses. Os dados foram coletados antes do início do experimento e com o intervalo de 15 dias até o final do experimento, os valores plasmáticos foram obtidos para mensuração das concentrações de glicose e insulina. Foram calculados os proxies G:I, RISQI, HOMA-IR e o MIRG. Foi realizado o teste de baixa dose de glicose oral (TBDGO) utilizando a área total sob a curva de glicose (ATG) e insulina (ATI) em três momentos, antes da indução a obesidade, após 90 e 150 dias. Os resultados foram submetidos à análise de variância considerando-se os efeitos de tempo e as médias comparadas com medidas repetidas pelo teste de Tukey, com o valor P≤0,05. A DI foi observada nos primeiros 90 dias de experimento, se caracterizando como um quadro de DI descompensada, apresentando um aumento dos níveis plasmáticos basais de glicose e insulina, pelas alterações em todos os proxies e com um aumento significativo da ATG (P<0,001) e ATI (P<0,05). Contudo, ficou evidente uma compensação do quadro de DI após 150 dias de experimento, sendo demonstrado pelos dados da resposta secretória insulínica das células ß do pâncreas, que se manifestaram pelo aumento dos níveis plasmáticos de insulina pós-jejum ou exposição à glicose gástrica com concomitante redução nos níveis de glicose e frutosamina pós-jejum e pela redução da ATG e pela marcada elevação de ATI (P<0,0001) no teste dinâmico. Tais achados comprovam a ocorrência de hiperinsulinemia associada à desregulação insulínica em equinos Mangalarga Marchador expostos a dietas à dieta hipercalórica.(AU)

Association between the screen time and the cardiorespiratory fitness with the presence of metabolic risk in schoolchildren / Associação entre o tempo de tela e a aptidão cardiorrespiratória e a presença de risco metabólico em escolares

ABSTRACT Objective: To verify the association between screen time and cardiorespiratory fitness with the presence of metabolic risk in schoolchildren in an isolated and clustered manner. Methods: Cross-sectional study with 1.200 schoolchildren from Santa Cruz do Sul-RS. Screen time and cardiorespiratory fitness were evaluated. The continuous metabolic risk score was calculated by summing the Z score of the waist circumference, systolic blood pressure, glucose, triglycerides, total cholesterol, low-density lipoprotein (LDL-C) and high-density lipoprotein (HDL-C). Results: Children (34.3%) and adolescents (48.2%) had high screen time, while 44.3% of the children and 53.3% of the adolescents were unfit in relation to cardiorespiratory fitness. Regarding the relation of screen time/cardiorespiratory fitness, 14.7% of the children and 26.9% of the adolescents presented high screen time and low levels of cardiorespiratory fitness. The presence of metabolic risk was shown in children (17.1%) and adolescents (14.7%). The presence of metabolic risk was directly associated with low levels of cardiorespiratory fitness in children and adolescents. When analyzed in clusters, the metabolic risk in children was 11% more prevalent in subjects with low screen time/unfit and 12% in subjects with high screen time/unfit, whereas in adolescents, the prevalence of metabolic risk was also higher in those with low screen time/unfit (8%) and high screen time/unfit (7%). Conclusions: The presence of metabolic risk in children and adolescents was associated with low levels of cardiorespiratory fitness, independent of screen time, in an isolated or clustered manner.

RESUMO Objetivo: Verificar a associação entre tempo de tela e aptidão cardiorrespiratória, de forma isolada e agrupada, e a presença de risco metabólico em escolares. Métodos: Estudo transversal com 1.200 escolares de Santa Cruz do Sul (RS). Foram avaliados o tempo de tela e a aptidão cardiorrespiratória. Foi calculado o escore de risco metabólico por meio da soma do escore Z, da circunferência da cintura, da pressão arterial sistólica, da glicose, dos triglicerídeos, do colesterol total, do colesterol da lipoproteína de baixa densidade (LDL) e do colesterol da lipoproteína de alta densidade (HDL). Resultados: Crianças (34,3%) e adolescentes (48,2%) apresentaram elevado tempo de tela, enquanto 44,3% das crianças e 53,3% dos adolescentes foram inaptos no tocante à aptidão cardiorrespiratória. Na relação tempo de tela/aptidão cardiorrespiratória, 14,7% das crianças e 26,9% dos adolescentes exibiram elevado tempo de tela e baixos níveis de aptidão cardiorrespiratória. A presença de risco metabólico foi evidenciada em crianças (17,1%) e em adolescentes (14,7%). A presença de risco metabólico esteve associada diretamente com baixos níveis de aptidão cardiorrespiratória nas crianças e nos adolescentes no que se refere às variáveis de forma isolada. Quando analisado de modo agrupado, o risco metabólico em crianças foi 11% mais prevalente em sujeitos com baixo tempo de tela/inaptos e 12% em sujeitos com elevado tempo de tela/inaptos, enquanto em adolescentes a prevalência de risco metabólico também foi superior nos escolares com baixo tempo de tela/inaptos (8%) e elevado tempo de tela/inaptos (7%). Conclusões: A presença de risco metabólico em crianças e adolescentes esteve associada com baixos níveis de aptidão cardiorrespiratória, independentemente do tempo de tela, tanto de modo isolado quanto agrupado.

Associations between dietary patterns and metabolic syndrome in adolescents / Asociación entre patrones de alimentación y síndrome metabólico en adolescentes

Abstract: Objective: Evaluate association of dietary patterns with metabolic syndrome (MetS) and metabolic markers. Materials and methods: 654 adolescents from Guadalajara, Jalisco, participated in a cross-sectional study. Diet was evaluated using a food frequency questionnaire; 24 food groups were integrated, and dietary patterns were derived using cluster analysis. MetS was defined according to International Diabetes Federation (IDF), Cook and colleagues, Ford and colleagues, and de Ferranti and colleagues criteria. Results: Dietary patterns identified were: "DP1", "DP2", and "DP3". Among males, "DP3" was associated with MetS (Cook and collaborators) (OR, 12.14; 95%CI, 1.66-89.05), hypertriglyceridemia (OR, 3.89; 95%CI, 1.01-15.07), and insulin resistance (OR, 6.66; 95%CI, 1.12-39.70). "DP2" was associated with abdominal obesity (OR, 5.11; 95%CI, 1.57-16.66). Conclusions: "DP3" entertained a greater risk of MetS, hypertriglyceridemia, and insulin resistance, while "DP2" possessed a greater risk of abdominal obesity among adolescent males.

Resumen: Objetivo: Evaluar la asociación de patrones dietarios (PD) con síndrome metabólico (SM) y marcadores metabólicos. Material y métodos: Estudio transversal con 654 adolescentes. Dieta evaluada con el cuestionario "frecuencia de consumos de alimentos"; se identificaron 24 grupos de alimentos, para obtener PD mediante análisis de conglomerados. SM se definió según los criterios: Federación de Diabetes Internacional (IDF), Cook y colaboradores, Ford y colaboradores y Ferranti y colaboradores. Resultados: Se identificaron tres PD: "PD1", "PD2" y "PD3". En hombres, "PD3" se asoció con SM (Cook y colaboradores) (RM, 12.14; IC95%, 1.66-89.05), hipertrigliceridemia (RM, 3.89; IC95%, 1.01-15.07) y resistencia a insulina (RM, 6.66; IC95%, 1.12-39.70). El patrón "PD2" se asoció con obesidad abdominal (RM, 5.11; IC95%, 1.57-16.66). Conclusiones: El patrón "PD3" aumenta el riesgo de SM, hipertrigliceridemia y resistencia a insulina y el "PD2" el riesgo de obesidad abdominal en adolescentes hombres.

Soluble insulin receptor and metabolic syndrome

The metabolic syndrome describes a group of signs that increase the likelihood for developing type 2 diabetes mellitus, cardiovascular diseases and some types of cancer. The action of insulin depends on its binding to membrane receptors on its target cells. We wonder if blood insulin could travel bound to proteins and if, in the presence of hyperinsulinemia, a soluble insulin receptor might be generated. We used young adult Wistar rats (which have no predisposition to obesity or diabetes), whose drinking water was added 20 % of sugar and that were fed a standard diet ad libitum for two and six months. They were compared with control rats under the same conditions, but that had running water for consumption. At two months, the rats developed central obesity, moderate hypertension, high triglyceride levels, hyperinsulinemia, glucose intolerance and insulin resistance, i.e., metabolic syndrome. Electrophoresis of the rats’ plasma proteins was performed, followed by Western Blot (WB) for insulin and for the outer portion of the insulin receptor. The bands corresponding to insulin and to the receptor external part were at the same molecular weight level, 25-fold higher than that of free insulin. We demonstrated that insulin, both in control animals and in those with hyperinsulinemia, travels bound to the receptor outer portion (ectodomain), which we called soluble insulin receptor, and that is released al higher amounts in response to plasma insulin increase; in rats with metabolic syndrome and hyperinsulinemia, plasma levels are much higher than in controls. Soluble insulin receptor increase in blood might be an early sign of metabolic syndrome.

Non-alcoholic fatty pancreatic disease and insulin resistance: overlooked complication of obstructive sleep apnea and hypopnea syndrome - signaling pathway diagram / Doença pancreática gordurosa não alcoólica e resistência insulínica: complicação negligenciada da síndrome de apneia e hipopneia obstrutiva do sono

Objective: To demonstrate the interaction between obstructive sleep apnea/hypopnea syndrome, insulin resistance, and non-alcoholic fatty pancreatic disease through the signaling pathway diagram. Methods: To investigate the involvement of metabolic signaling pathway, a search was performed using the Kyoto Encyclopedia of Genes and Genomes. The signaling pathway mapping was performed using the automatic annotation server of this encyclopedia. The Modeller 9.19 package was used to predict 3-dimensional structures based on the homology modeling protocol. The signaling pathway map was performed using PathVisio software, which is a free available signaling pathway drawing software. Based on the 3-dimensional structures, we have designed several peptide activators of the signaling pathway of non-alcoholic fatty pancreatic disease. Results: The contigs were taken from the Kyoto Encyclopedia of Genes and Genomes database and their mapped transcription represented the signaling pathway of the main biomolecules that triggered non-alcoholic fatty pancreatic disease. The interaction between obstructive sleep apnea/hypopnea syndrome, insulin resistance, and inflammatory factors contributes to the possible development of fatty infiltration of pancreas, leading to the loss of function of the pancreatic ß-cells, and even to the development of other metabolic diseases. Conclusion: The interaction between obstructive sleep apnea/hypopnea syndrome and insulin resistance demonstrated through the signaling pathway contributes to the possible development of non-alcoholic fatty pancreatic disease. (AU)

Objetivo: Demonstrar a interação entre a síndrome de apneia/ hipopneia obstrutiva do sono, a resistência à insulina e a doença pancreática gordurosa não alcoólica considerando o desenho de uma via de sinalização. Métodos: Para avaliar o envolvimento da via de sinalização metabólica, realizou-se uma pesquisa usando a Enciclopédia de Genes e Genomas de Kyoto. O mapeamento da via de sinalização foi realizado com o servidor de anotação automático desta enciclopédia. O software MODELLER 9.19 foi usado para prever estruturas tridimensionais, com base no protocolo de modelagem por homologia. O desenho da via de sinalização foi realizado por meio do programa PathVisio, um software de domínio público para desenho de via de sinalização. Com base nas estruturas tridimensionais, desenhamos os vários ativadores peptídicos da via de sinalização da esteatose pancreática. Resultados: Os contigs foram retirados do banco de dados da Enciclopédia de Genes e Genomas de Kyoto, e sua transcrição mapeada representou a via de sinalização das principais biomoléculas que desencadearam doença pancreática gordurosa não alcoólica. A interação entre síndrome de apneia/hipopneia obstrutiva do sono, resistência à insulina e fatores inflamatórios contribuiu para o possível desenvolvimento de infiltração gordurosa do pâncreas, levando à perda de função das células beta pancreáticas e até mesmo ao desenvolvimento de outras doenças metabólicas. Conclusão: A interação entre síndrome de apneia/hipopneia obstrutiva do sono e resistência à insulina demonstrada pela via de sinalização contribui para o possível desenvolvimento de doença pancreática gordurosa não alcoólica. (AU)

Evidências científicas sobre a associação entre burnout e síndrome metabólica: revisão integrativa / Evidencias científicas sobre la asociación entre el burnout y el síndrome metabólico: revisión integradora / Scientific evidence on the association between burnout and metabolic syndrome: integrative review

Resumo Objetivo Avaliar as evidências científicas disponíveis na literatura sobre a associação entre Síndrome de Burnout e Síndrome Metabólica. Métodos Revisão integrativa da literatura, com buscas nas bases de dados do Cumulative Index to Nursing and Allied Health Literature, National Library of Medicine National Institutes of Health, Web of Science, Scopus, Cochrane Library, Latin American and Caribbean Center on Health Sciences Information, Scientific Eletronic Library Online e Springer Link. Os artigos selecionados foram analisados de acordo com a Agency for Healthcare Research and Quality. Resultados A maioria (80%) dos 5 artigos que atenderam aos critérios de seleção estava na língua inglesa e indexada nas bases de dados Web of Science e Scopus. Dentre os trabalhos, 80% tinham médicos como autores principais. O continente asiático (Israel, Japão e China) concentrou a maior parte de produção. Não ocorreu predominância de desenho de estudo. A área financeira correspondeu a 60% do público pesquisado. Conclusão As evidências disponíveis na literatura são incipientes, apenas 20% dos artigos elegíveis apresentou associação entre as síndromes estudadas e os demais, indicam associação entre Burnout e componentes da SM separadamente.

Resumen Objetivo evaluar las evidencias científicas disponibles en la literatura sobre la asociación entre el síndrome de burnout y el síndrome metabólico. Métodos revisión integradora de la literatura, con búsquedas en las bases de datos del Cumulative Index to Nursing and Allied Health Literature, National Library of Medicine National Institutes of Health, Web of Science, Scopus, Cochrane Library, Latin American and Caribbean Center on Health Sciences Information, Scientific Eletronic Library Online y Springer Link. Los artículos seleccionados fueron analizados de acuerdo con la Agency for Healthcare Research and Quality. Resultados la mayoría (80%) de los cinco artículos que cumplieron los criterios de selección estaba en inglés e indexada en las bases de datos Web of Science y Scopus. Entre los trabajos, 80% tenía médicos como autores principales. El continente asiático (Israel, Japón y China) concentró la mayor parte de la producción. No ocurrió predominio de diseño de estudio. El área financiera correspondió al 60% del público investigado. Conclusión las evidencias disponibles en la literatura son incipientes, solo el 20% de los artículos elegibles presentó asociación entre los síndromes estudiados y los demás indican asociación entre burnout y componentes del SM separadamente.

Abstract Objective To evaluate the scientific evidence available in the literature on the association between Burnout Syndrome and Metabolic Syndrome. Methods Integrative literature review, searching the databases of the Cumulative Index to Nursing and Allied Health Literature, National Library of Medicine, National Institutes of Health, Web of Science, Scopus, Cochrane Library, Latin American and Caribbean Center on Health Sciences Information, Scientific Eletronic Library Online and Springer Link. The selected articles were analyzed according to the Agency for Healthcare Research and Quality. Results Most (80%) of the 5 studies that met the selection criteria were in English language and indexed in the Web of Science and Scopus databases. Among the studies, 80% had physicians as the main authors. The Asian continent (Israel, Japan and China) concentrated the majority of production. There was no predominance of study design. The financial area corresponded to 60% of the study participants. Conclusion The available evidence in the literature is incipient, only 20% of the eligible articles showed association between the syndromes studied and the others, indicate association between Burnout and MS components separately.

La ingesta de "once", en reemplazo de la cena, se asocia al riesgo de presentar síndrome metabólico / Five o'clock tea and the risk of metabolic syndrome

Background: Seventy four percent of Chileans replaced the traditional dinner for the consumption of "five o'clock tea" (5CT), a mealtime that includes bread and is simliar to western breakfast. The latter favors the intake of unhealthy foods. Aim: To study whether the consumption of "5CT", instead of dinner, could be a risk factor for the development of metabolic syndrome (MetSyn). Material and Methods: Anthropometric parameters, mean blood pressure, lipid profile, thyroid stimulating hormone and fasting glucose were measured in 489 subjects aged 39 ± 12 years (33% women) who attended a primary cardiovascular prevention (CV) program. A 24-hour recall and usual meal times were registered during a dietary interview. To determine the association between the consumption of "5CT" or dinner and the probability of presenting two or more components of MetSyn, we built an odds proportional model adjusted by age and sex. In addition, severity for MetSyn was calculated. Results: Nineteen percent of participants had MetSyn and 39%, two or more MetSyn components. Those who consumed "5CT" instead of dinner, had 54% more probability of having 2 or more MetSyn components (Odds ratio = 1.54, confidence intervals 1.032.32, p = 0.04). Participants who included processed carbohydrates in their last meal had a higher probability of having components of MetSyn. This probability decreased among participants who ate dinner with a low proportion of refined carbohydrates. Conclusions: Subjects who eat "5CT", instead of dinner as the last meal, have a higher cardiometabolic risk and MetSyn severity.

Intra-abdominal fat measurement by ultrasonography: association with anthropometry and metabolic syndrome in adolescents / Gordura intra-abdominal medida por ultrassonografia: relação com antropometria e síndrome metabólica em adolescentes

Abstract Objective: To associate intra-abdominal fat thickness measured by ultrasonography to the factors related to metabolic syndrome and to determine cutoff points of intra-abdominal fat measurement associated with a greater chance of metabolic syndrome in adolescents. Methods: This was a cross-sectional study, with 423 adolescents from public schools. Intra-abdominal fat was measured by ultrasonography. Anthropometric data were collected, and biochemical analyses were performed. Results: Intra-abdominal fat was measured by ultrasonography, showing a statistically significant association with the diagnosis of metabolic syndrome (p = 0.037), body mass index (p < 0.001), elevated triglyceride levels (p = 0.012), decreased plasma HDL levels (p = 0.034), and increased systemic blood pressure values (p = 0.023). Cutoff values of intra-abdominal fat thickness measurements were calculated by ultrasound to estimate the individuals most likely to develop metabolic syndrome. In the logistic regression models, the cutoff values that showed the highest association with metabolic syndrome in males were 4.50, 5.35, 5.46, 6.24, and 6.50 cm for the ages of 14, 15, 16, 17, and 18/19 years, respectively. In the female gender, the cutoff values defined for the same age groups were 4.46, 4.55, 4.45, 4.90, and 6.46 cm. In an overall analysis using the ROC curve, without gender and age stratification, the cut-off of 3.67 cm showed good sensitivity, but low specificity. Conclusion: Ultrasonography is a useful method to estimate intra-abdominal adipose tissue in adolescents, which is associated with the main factors related to obesity and metabolic syndrome.

Resumo Objetivo: Relacionar a espessura da gordura intra-abdominal medida pela ultrassonografia aos fatores ligados à síndrome metabólica. Determinar pontos de corte da medida da gordura intra-abdominal associados a uma maior chance de síndrome metabólica em adolescentes. Métodos: Estudo seccional, com 423 adolescentes de escolas públicas. A gordura intra-abdominal foi medida pela ultrassonografia. Foram coletados dados antropométricos e feitas análises bioquímicas. Resultados: As medidas da gordura intra-abdominal por ultrassonografia apresentaram associação estatisticamente significativa com o diagnóstico de síndrome metabólica (p = 0,037), índice de massa corporal (p < 0,001), níveis elevados de triglicerídeos (p = 0,012), redução dos níveis plasmáticos de HDL (p = 0,034) e aumento da pressão arterial sistêmica (p = 0,023). Calcularam-se pontos de corte da medida da espessura da gordura intra-abdominal por ultrassom, para estimar os indivíduos com mais chance para o desenvolvimento de síndrome metabólica. Em modelos de regressão logística, os pontos de corte que apresentaram maior associação com a síndrome metabólica no sexo masculino foram de 4,50, 5,35, 5,46, 6,24 e 6,50 cm para as idades de 14, 15, 16, 17 e 18/19 anos, respectivamente. No sexo feminino, os pontos de corte definidos para as mesmas faixas etárias foram de 4,46, 4,55, 4,45, 4,90 e 6,46 cm. Em análise global por meio da curva ROC, sem estratificações por sexo e idade, o ponto de corte de 3,67 cm teve boa sensibilidade, porém apresentou baixa especificidade. Conclusão: A ultrassonografia é um método útil para a estimativa do tecido adiposo intra-abdominal em adolescentes, está associada com os principais fatores relacionados à obesidade e à síndrome metabólica.

Síndrome metabólico en pacientes hospitalizados en Servicio de Geriatría / Metabolic syndrome in patients hospitalized in Geriatric Services

RESUMEN Introducción: la prevalencia del síndrome metabólico, a nivel mundial, es muy elevada y continúa en aumento vertiginosamente en los últimos años. Por lo que se puede considerar una pandemia de la época contemporánea, se estima que el 25 % de la población adulta la padece. Objetivo: determinar la prevalencia del síndrome metabólico e identificar otras formas clínicas de enfermedad vascular ateroesclerótica, en gerontes hospitalizados en Servicios de Geriatría del Hospital Provincial Clínico Quirúrgico Docente "Celia Sánchez Manduley", Manzanillo, Granma; en el período comprendido entre junio 2015 a junio 2016. Materiales y métodos: se realizó estudio observacional, descriptivo, de corte transversal. Se incluyeron los 120 senescentes que ingresaron en los Servicios de Geriatría. Resultados: se estableció el diagnóstico de síndrome metabólico en 105 individuos de 120 sujetos estudiados. El grupo de 70-79 años de edad y el sexo masculino fueron los más afectados por la endocrinopatía. Las otras formas clínicas de enfermedad vascular ateroesclerótica que se identificaron en los senescentes estudiados, fueron: cardiopatía isquémica, enfermedad cerebrovascular y cardiopatía hipertensiva. Conclusiones: existe una alta prevalencia del síndrome metabólico en los adultos mayores estudiados.

ABSTRACT Introduction: the prevalence of the metabolic syndrome is very high around the world and is still vertiginously increasing in the last years. Therefore, it can be considered a pandemic of the current times. It is thought that 25 % of the adult population suffers it. Objective: to determine the prevalence of the metabolic syndrome and to identify other clinical forms of the atherosclerotic vascular disease in elder people who entered the Service of Geriatrics of the Provincial Teaching Clinical Surgical Hospital "Celia Sanchez Manduley", of Manzanillo, Granma, in the period from June 2015 to June 2016. Materials and methods: a cross-sectional, observational, descriptive study was carried out with the inclusion of the 120 elder people who the Service of Geriatrics. Results: 105 individuals of 129 studied were diagnosed with metabolic syndrome. The 79-79 age group and male sex were the most affected by endocrinopathy. Other clinical forms of the arteriosclerotic vascular disease identified in the studied elder people were ischemic heart disease, cerebrovascular disease and hypertensive heart disease. Conclusions: there is a high prevalence of the metabolic syndrome among the studied elder people.

Relación entre niveles de actividad física y sedentarismo con síndrome metabólico. ENS Chile 2009-2010 / Relationship between levels of physical activity and sedentarism with metabolic syndrome. ENS Chile 2009-2010

Resumen: Objetivo: Asociar una nueva e integradora clasificación de actividad física (AF) y sedentarismo con riesgo de síndrome metabólico (SM) en una muestra representativa de adultos chilenos. Material y métodos: Se incluyeron 5040 participantes de la Encuesta Nacional de Salud de Chile 2009-2010. Fueron creadas cuatro categorías mediante una combinación entre niveles de AF y sedentarismo (SED) usando el cuestionario GPAQ. El SM fue definido según las normas del NCEP ATP-III. Resultados: Se observa una menor probabilidad de presentar SM sólo en las categorías que cumplen con las recomendaciones internacionales de AF (p<0.05), "activo y bajo-SED" (RM=0.72 [0.57 a 0.91]) y "activo y alto-SED" (RM=0.63 [0.49 a 0.81]). El nivel de sedentarismo (alto/bajo) no se asoció con una reducción significativa de SM en ninguno de los grupos. Conclusiones: Este tipo de clasificación demuestra que la principal estrategia para reducir el riesgo de SM debiera estar asociada con cumplir las recomendaciones de AF.

Abstract: Objective: To use a new methodology to classify the level of physical activity (PA) by combining the levels of PA and sedentary time (SED) in order to establish its association with metabolic syndrome (MS). Materials and methods: A representative sample of Chilean adults (≥18 years old) who participated in the National Health Survey (ENS 2009-2010) was included in this study (n=5 040). Four categories were created using a combination of PA and SED levels through the GPAQ questionnaire. MS was defined according to the norms established by NCEP ATP-III. Results: A lower probability of MS was observed only in the categories that comply with the international recommendations of PA, "active and low-SED" (OR=0.72 [0.57 to 0.91]) and "active and high-SED" (OR=0.63 [0.49 to 0.81]). While the level of SED (high/low) was not associated with a significant reduction of MS in any of the groups. Conclusions: This type of classification demonstrates that the main strategy to reduce the risk of MS should be associated with compliance with the recommendations of PA.

The prevalence of metabolic syndrome in the different phenotypes of polycystic ovarian syndrome / A prevalência da síndrome metabólica nos diferentes fenótipos da síndrome do ovário policístico

Abstract Objective To evaluate the prevalence of metabolic syndrome (MetS) in the phenotypes of polycystic ovarian syndrome (PCOS). Methods This was a cross-sectional study involving 111 women aged between 18 and 39 years old diagnosed with PCOS, according to the Rotterdam Criteria, and grouped into four phenotypes: A: ovulatory dysfunction + hyperandrogenism + polycystic ovaries; B: ovulatory dysfunction + hyperandrogenism; C: hyperandrogenism + polycystic ovaries; D: ovulatory dysfunction + polycystic ovaries. To evaluate the presence of MetS, wemeasured serum triglyceride levels, HDL cholesterol, fasting blood glucose, blood pressure, and waist circumference. Results The prevalence of MetS found in this sample was 33.6%, and there was no statistically significant difference (p < 0.05) among the 4 phenotypes. However, phenotype D presented a significantly higher mean glucose level after fasting (93.6 mg/dL) and 2 hours after ingesting a solution with 75 g of anhydrous glucose (120 mg/dL), as well as the lowest mean level of high-density lipoprotein (HDL) cholesterol (44.7 mg/dL). The women in this group demonstrated a high prevalence of abdominal circumference ≥ 80 cm (68.2%), as well as the highest mean abdominal circumference (90.1 cm). Amongst the women with an abdominal circumference ≥ 80 cm, phenotype A increased approximately six-fold the chance of developing metabolic syndrome in relation to phenotype C. Conclusion The four phenotypes of PCOS demonstrated similar prevalence rates of metabolic syndrome; abdominal obesity presented a relevant role in the development of metabolic alterations, regardless of the phenotype.

Resumo Objetivo Avaliar a prevalência da síndromemetabólica nos fenótipos da síndrome do ovário policístico. Métodos Trata-se deum estudo transversal envolvendo 111 mulheres comidade entre 18 e39 anos com diagnóstico de síndrome do ovário policístico, segundo os critérios de Roterdã, e agrupadas em quatro fenótipos: A: Disfunção ovulatória + hiperandrogenismo + ovários policísticos;B: disfunçãoovulatória + hiperandrogenismo; C: hiperandrogenismo + ovários policísticos; D: disfunção ovulatória + ovários policísticos. Para avaliar a presença de síndrome metabólica, foram medidos os níveis séricos de triglicérides, colesterol HDL e glicemia de jejum, pressão arterial e circunferência da cintura. Resultados A prevalência de síndrome metabólica encontrada nesta amostra foi de 33,6%, e não houve diferença estatisticamente significativa (p < 0,05) entre os quatro fenótipos. Entretanto, o fenótipo D apresentou um nível médio de glicose significativamente mais alto após o jejum (93,6 mg/dL) e duas horas após a ingestão de uma solução com 75g de glicose anidra (120 mg/dL), bem como o menor nível médio de colesterol HDL (44,7 mg/dl). As mulheres deste grupo demonstraram alta prevalência de circunferência abdominal ≥ 80 cm (68,2%), bem como a maior média de circunferência abdominal (90,1 cm). Entre as mulheres com circunferência abdominal ≥ 80 cm, o fenótipo A aumentou em aproximadamente 6 vezes a chance de desenvolver síndrome metabólica em relação ao fenótipo C. Conclusão Os quatro fenótipos da síndrome do ovário policístico demonstraram taxas semelhantes de prevalência de síndrome metabólica; a obesidade abdominal apresentou papel relevante no desenvolvimento de alterações metabólicas, independentemente do fenótipo.

Associação entre fatores sociodemográficos e comportamentais com a síndrome metabólica em pessoas vivendo com HIV / Asociación entre factores sociodemográficos y comportamentales con el síndrome metabólico en personas viviendo con VIH / Association between sociodemographic and behavioral factors with metabolic syndrome in people living with HIV

Resumo OBJETIVOS Verificar a associação entre os fatores sociodemográficos e comportamentais com a síndrome metabólica em pessoas vivendo com HIV. MÉTODOS Estudo transversal, realizado em ambulatórios especializados no município de Ribeirão Preto - SP, entre outubro de 2014 a outubro de 2016. Para avaliação da síndrome metabólica utilizou-se os critérios do National Cholesterol Education Program Adult Treatment Panel III e da International Diabetes Federation. Foram realizadas entrevistas individuais e utilizou-se o teste qui-quadrado e exato de Fisher. RESULTADOS Foram avaliados 340 pacientes, 28,5% (n=97) com SM pelo critério do National Cholesterol Education Program Adult Treatment Panel III, e 39,4% (n=134) pela International Diabetes Federation. Houve associação entre a síndrome metabólica e as variáveis sexo (ATP: p<0,001; IDF: p=0,002), idade (ATP: p<0,001; IDF: p<0,001), escolaridade (ATP: p=0,003; IDF: p=0,003), estado civil (ATP: p=0,003; IDF: p=0,022), situação de trabalho (ATP: p=0,003; IDF: p=0,024), orientação sexual (ATP: p=0,003; IDF: p=0,015), hábitos de fumar (ATP: p=0,037; IDF: p=0,033) e atividades de lazer (ATP: p=0,010; IDF: p=0,006). CONCLUSÕES Existem associações significativas entre a síndrome metabólica, fatores sociodemográficos e comportamentais em pessoas vivendo com HIV.

Resumen OBJETIVO Verificar la asociación entre factores sociodemográficos y comportamentales con el síndrome metabólico en personas que viven con VIH/SIDA. MÉTODOS Estudio transversal, realizado en ambulatorios especializados en la ciudad de Ribeirão Preto-SP, entre octubre de 2014 y octubre de 2016. Para la evaluación de la SM se utilizaron los criterios del National Cholesterol Education Program Adult Treatment III y de la International Diabetes Federation. Se realizaron entrevistas individuales y se utilizó el test Qui-cuadrado y exacto de Fisher. RESULTADOS Se evaluaron 340 pacientes, 28,5% (n = 97) con SM por el criterio del National Cholesterol Education Program Adult Treatment III, y el 39,4% (n = 134) por el IDF. En el presente estudio se evaluó la relación entre el síndrome metabólico y las variables sexo (ATP: p<0,001, IDF: p=0,002), edad (ATP: p<0,001; IDF: p<0,001), escolaridad (ATP: p=0,003; IDF: p=0,003), estado civil (ATP: p=0.003, IDF: p=0.022), situación de trabajo (ATP: p=0,003, IDF: p=0,024), los hábitos de fumar (ATP: p=0,037, IDF: p=0,033) y actividades de ocio (ATP: p=0,010; IDF: p=0,006). CONCLUSIONES Existen asociaciones significativas entre el síndrome metabólico, factores sociodemográficos y comportamentales en personas que viven con VIH/SIDA.

Abstract OBJECTIVE To analyze the association between sociodemographic and behavioral factors with the metabolic syndrome in people living with HIV. METHODS A cross-sectional study was carried out in specialized outpatient clinics in Ribeirão Preto - SP city, between October 2014 and October 2016. The criteria of the National Cholesterol Education Program Adult Treatment Panel III and the International Diabetes Federation were used for the evaluation of metabolic syndrome. Individual interviews were conducted and the Chi-square and Fisher's exact test was used. RESULTS 340 patients were evaluated, 28.5% (n=97) with metabolic syndrome by the National Cholesterol Education Program Adult Treatment Panel III criterion, and 39.4% (n=134) by the International Diabetes Federation. There was an association between MS and the variables gender (ATP: p<0.001, p=0.002), age (ATP: p<0.001, IDF: p<0.001), schooling (ATP: p=0.003, IDF: p=0.003), marital status (ATP: p=0.003, IDF: p=0.022), work status (ATP: p=0.003; IDF: p=0.024), smoking (ATP: p=0.037, IDF: p=0.033) and leisure activities (ATP: p=0.010, IDF: p=0.006). CONCLUSIONS There are significant associations between the metabolic syndrome, sociodemographic and behavioral factors in people living with HIV.

Metabolic and hormonal assessment of adolescent and young adult women with prior premature adrenarche

OBJECTIVE: Follow-up studies of girls with premature adrenarche have reported the development of polycystic ovary syndrome, insulin resistance, and dyslipidemia and a propensity to cardiovascular disease. The aim of this study was to analyze the presence of these conditions in patients previously treated at the Universidade Federal do Triângulo Mineiro. METHODS: A total of 130 medical records reported premature adrenarche. One hundred and twenty-two patients were invited to participate, of whom 54 accepted; 34 patients were selected, as they had reached their final height. Anthropometric, blood glucose, insulin, and lipid and hormonal profile (LH, FSH, estradiol, 17α-OH-progesterone, androstenedione, dehydroepiandrosterone sulfate, testosterone) data were obtained, the HOMA-IR index was calculated, and pelvic ultrasonography was performed. To characterize polycystic ovary syndrome and metabolic syndrome, the Rotterdam and International Diabetes Federation criteria, respectively, were used. Data were analyzed according to measures of dispersion, frequency and correlations of interest. RESULTS: The age of the participants ranged from 15.2 to 28.2 years/months; 23.5% of the patients were overweight, 11.8% were obese, 29.4% had a large waist circumference, and 8.8% were hypertensive. None of the patients had altered glucose levels, and insulin levels and HOMA-IR were elevated in 29.4% and 38.2% of the participants, respectively; 14.7% of the patients exhibited acanthosis nigricans. The lipid profiles of the participants were variable, and one patient (2.9%) had metabolic syndrome. Polycystic ovary syndrome was found in 41.2% of patients. CONCLUSION: The percentage of patients with polycystic ovary syndrome who also had overweight, obesity and insulin resistance corroborates the literature data about the need for follow-up aiming at interventions, especially for conditions associated with cardiometabolic risk.